Demand reduction for new psychoactive substances: drug abuse prevention, risk reduction and treatment

Article Sidebar

DOI: https://doi.org/10.28931/riiad.2020.1.06

Main Article Content

Elena Hedoux
Grupo de Cooperación para Combatir el Abuso y el Tráfico Ilícito de Drogas (Grupo Pompidou) Consejo de Europa.

Abstract

En los últimos años ha habido un aumento sin precedentes en el número, tipo y disponibilidad de nuevas sustancias psicoactivas (NPS, por sus siglas en inglés) en diversas regiones del mundo. El crecimiento en este mercado también es responsable del aumento de daños graves reportados recientemente. Los desafíos clave giran en torno a la velocidad a la que aparecen las NPS, su proliferación rápida y abierta, y la información limitada o nula sobre sus efectos y daños.

Published: Jun 13, 2020

Article Details

How to Cite
Hedoux, E. (2020). Demand reduction for new psychoactive substances: drug abuse prevention, risk reduction and treatment. Revista Internacional De Investigación En Adicciones, 6(1), 45–47. https://doi.org/10.28931/riiad.2020.1.06
Issue
Vol. 6 No. 1 (2020): January - June, 2020
Section
Experts Opinions
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors retain copyright of their articles. Works published in RIIAD are distributed under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) licence.

References

Elliott, S., & Evans, J. (2014). A 3-year review of new psychoactive substances in casework. Forensic Science International, 243, 55-60. doi: 10.1016/j.forsciint.2014.04.017

European Monitoring Centre for Drugs and Drug Addiction and Eurojust. (2016). New psychoactive substances in Europe: Legislation and prosecution - current challenges and solutions. EMCDDA–Eurojust joint publication, Publications Office of the European Union, Luxembourg.

European Monitoring Centre for Drugs and Drug Addiction. (2015). New psychoactive substances in Europe. An update from the EU Early Warning System (March 2015). Publications Office of the European Union, Luxembourg.

European Monitoring Centre for Drugs and Drug Addiction. (2016). Health responses to new psychoactive substances. Publications Office of the European Union, Luxembourg.

King, L. A., & Kicman, A. T. (2011). A brief history of “new psychoactive substances”. Drug Testing and Analysis, 3(7-8), 401-403. doi: 10.1002/dta.319

Móró, L. (2014). Harm reduction of novel psychoactive substance use. En: G. R. Potter, M. Wouters, & J. Fountain (Eds.). Change and continuity: researching evolving drug landscapes in Europe, (pp. 36-50). Lengerich: Pabst Science Publishers.

Pompidou Group (2017). Observations on trends and new insights concerning NPS by the participants of the 2017 Executive Training for the attention of the Permanent Correspondents of the Pompidou Group. Recuperado de https://rm.coe.int/observations-on-trends-and-new-insights-concerning-nps-by-the-particip/168076cf15

Winstock, A. R., & Mitcheson, L. (2012). New recreational drugs and the primary care approach to patients who use them. BMJ, 344, e288-e288. doi: 10.1136/bmj.e288